Stereochemistry | ABSOLUTE |
Molecular Formula | C21H24Cl2N2O.ClH |
Molecular Weight | 427.795 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN([C@H](CN1CCCC1)C2=CC=CC=C2)C(=O)CC3=CC=C(Cl)C(Cl)=C3
InChI
InChIKey=VFLWVWZSDBTGQJ-VEIFNGETSA-N
InChI=1S/C21H24Cl2N2O.ClH/c1-24(21(26)14-16-9-10-18(22)19(23)13-16)20(15-25-11-5-6-12-25)17-7-3-2-4-8-17;/h2-4,7-10,13,20H,5-6,11-12,14-15H2,1H3;1H/t20-;/m1./s1
Molecular Formula | C21H24Cl2N2O |
Molecular Weight | 391.334 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
1.6 nM [EC50] | |||
0.04 nM [Ki] | |||
53.0 nM [Ki] | |||
24.0 nM [Ki] | |||
26.0 nM [IC50] | |||